跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 3,093 条关于
“IGLV3-21”
全部
3,093
临床试验
615
药物
331
机构
104
资讯
2,043
4个月前
Largest Blood Protein Genetics Study Reveals New Precision Medicine Opportunities, Including TYK2 Inhibitor Repurposing for Rheumatoid Arthritis
去年
AAO 2024: 3D-Printed Glasses, ANX007 for Geographic Atrophy, and Cataract Surgery Risks Highlighted
去年
MD Anderson Highlights: Modified NRF2 Activator Reverses Chronic Pain, Canakinumab Shows Promise in MDS Subgroup
去年
Merck's CAPVAXIVE Shows Promise Against Pneumococcal Disease in Adults
去年
FDA Approves Abrysvo for RSV Prevention in Adults 18-59 at Increased Risk
去年
MD Anderson Research Highlights: Modified NRF2 Activator, Canakinumab in MDS, and More
去年
Grifols Receives $21 Million Grant to Identify Parkinson's Disease Biomarkers
去年
FDA Approves Capvaxive, First Adult-Specific 21-Valent Pneumococcal Vaccine
去年
LENZ Therapeutics' LNZ100 NDA Accepted by FDA for Presbyopia Treatment
2年前
CDC Recommends 21-Valent Pneumococcal Conjugate Vaccine (PCV21) for Adults
第 1 页,共 205 页
上一页
下一页